MHB018A Treatment in Patients With Active Thyroid Eye Disease

Clinical trial NCT06989918 · RECRUITING

Trial details

NCT number: NCT06989918
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Associated Ophthalmopathies

Start date: 2025-07-22
Primary completion: 2026-07-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.